Opnext, Inc. (OPXT) Posts Q2 EPS Loss of $0.07, Sales Fall Short

Opnext, Inc. (NASDAQ: OPXT) reported Q2 EPS of ($0.07), $0.01 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $86 million versus the consensus estimate of $92.67 million.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c